Non-Germinal Center B-cell Diffuse Large B-cel... - CLL Support

CLL Support

22,618 members38,849 posts

Non-Germinal Center B-cell Diffuse Large B-cell Lymphoma (DLBCL) may benefit most from Immunochemotherapy.

AussieNeil profile image
AussieNeilPartnerAdministrator
4 Replies

"Progression-free and overall survival were significantly longer in patients with non-GCB DLBCL who were treated with R-ACVBP compared with R-CHOP. No differences in survival between regimens were found for patients with GCB DLBCL."

More from the Cancer Network:

cancernetwork.com/news/non-...

Good to see there is work going on in (from Paris, France in this case) into what works best for the different types of DLBCL

Neil

Photo: Flowering sundew

Written by
AussieNeil profile image
AussieNeil
Partner
To view profiles and participate in discussions please or .
4 Replies
Cllcanada profile image
CllcanadaTop Poster CURE Hero

Actually, Non-Germinal Center B -Cell like DLBCL is not a Richter's transformation, per say, it is Activated B-cell like ABC-DLBCL or perhaps not otherwise specified or NOS-DLBCL, subtype.

RT-DLBCL is different genetically... and has two further subtypes... CLL clonal related and denovo.

en.m.wikipedia.org/wiki/Ger...

Anyway... ABC type is the hardest to treat, so this cocktail is good news... Also Imbruvica (ibrutinib) has shown to be active in this type.

A Phase II study in DLBCL found a clinically meaningful response to ibrutinib monotherapy (overall response rate [ORR] 40%, CR 8%) in the activated B-cell-like (ABC) molecular subtype, but not in the germinal B-cell-like (GBC) subtype (ORR 5%, CR 0%). Median PFS in the ABC responders was 5.5 months.

lymphomahub.com/agents/agen...

Here is the full paper

jco.ascopubs.org/content/ea...

~chris

AussieNeil profile image
AussieNeilPartnerAdministrator in reply to Cllcanada

Thanks for the correction Chris. Are you able to reassure our community that there's virtually no risk of developing Non-Germinal Center B -Cell like DLBCL if you have CLL?

I've changed the title.

Neil

Cllcanada profile image
CllcanadaTop Poster CURE Hero in reply to AussieNeil

DLBCL is highly aggressive... any type... I know...

De novo could be any subtype of DLBCL ...it is MUCH more secondary cancer than a true Richter's... which is clearly CLL clone related in 80% of cases... but it might be related to the brake failure on the CLL immune system car post treatment...

This will be likely reclassified based on new genetic data... CLL and NOS

perhaps?

It is just how fine you want to slice the salami :-)

Richter's is VERY POORLY understood.. no reassurances... but RCHOP can and has been curative...

My prognosis... 6 months to a year... now I'm 24 months...

Don't believe the numbers, believe in yourselves... every day is a gift

Psmithuk profile image
Psmithuk in reply to Cllcanada

keep going - five years next! All the best

Chris(UK)

You may also like...

How many of us develop large b cell lymphomas

Sll lymphoma small B cell

Acalabrutinib exhibits comparable efficacy, superior safety to ibrutinib for CLL (finally!)

numerically favourable overall survival. Overall, the safety and tolerability of Calquence were...

ASH 2018: ECOG trial shows superiority of Ibrutinib and rituximab over FCR

superior to FCR for both overall and progression free survival for frontline patients <70 years...

Clinical Utility of Chromosomal Microarray in Richter's Transformation

ASH 2019 looks at 24 patients with a diagnosis of Richter transformation to DLBCL with a prior...